Position in AMGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$152,546,325
+$17,736,174 QoQ
Shares Held
433,555
+5.3% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 59.375165780581476.ToString("F0")%
Shared 17.276008810877514.ToString("F0")%
None 23.348825408541014.ToString("F0")%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Mar 31, 2026CallValue
$105,555
CallShares
300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Cerity Partners LLC holds $2,080,837,635 across 16 Drug Manufacturers - General names. AMGN ranks #5 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
732,549 | $673,776,592 | |
| 2 | JNJ |
Johnson & Johnson
|
1,846,524 | $451,364,326 | |
| 3 | ABBV |
AbbVie Inc.
|
1,215,422 | $264,342,129 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,639,510 | $197,216,656 | |
| 5 | AMGN |
Amgen Inc
This page
|
433,555 | $152,546,325 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,392,773 | $84,471,681 | |
| 7 | AZN |
Astrazeneca PLC
|
301,215 | $59,405,621 | |
| 8 | NVS |
Novartis AG
|
329,910 | $50,393,751 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $105,555 | 300 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $152,546,325 | 433,555 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $134,810,151 | 411,873 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $117,446,560 | 416,182 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $118,111,134 | 423,019 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $126,503,942 | 406,047 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $101,424,928 | 389,138 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $127,360,913 | 395,273 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $107,869,925 | 345,239 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $108,888,589 | 382,979 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $76,735,728 | 266,425 | Shares | Other | 2024-01-26 | |
| 2023-09-30 | $65,310,023 | 243,005 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $62,215,776 | 280,226 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $56,691,825 | 234,506 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $50,566,079 | 192,530 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $19,796,431 | 87,828 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,260,283 | 87,383 | Shares | Other | 2022-08-10 | |
| 2022-03-31 | $8,663,926 | 35,828 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $7,458,655 | 33,154 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,452,983 | 25,643 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $5,345,193 | 21,929 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $5,396,440 | 21,689 | Shares | Sole | 2021-08-11 | |
| 2020-12-31 | $5,419,444 | 23,571 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $5,742,491 | 22,594 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,336,521 | 18,386 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $3,570,886 | 17,614 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||